Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579566 · ClinicalTrials.gov registry record
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
A clinical trial of Sarcoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 7
- Study locations
NCT00579566: Recruiting study of Sarcoma, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579566 is a study of Sarcoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3,000 participants, above the 897-participant average among 122 other Sarcoma trials with a reported enrollment target (234% higher). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579566, a study of Sarcoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.
Primary Outcome
for laboratory-based studies on the causes, prevention, diagnosis and treatment of human soft tissue sarcoma
Conditions Studied
Interventions
- OTHER Specimen protocol
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent and Follow-Up) - Commack
- Memorial Sloan Kettering Westchester (Consent and Followup) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (Consent and Followup) - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and Followup) - Middletown
- Memorial Sloan Kettering Bergen (Consent and Follow up) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2002-06 |
| Est. Completion | 2026-06 |
What NCT00579566 shows while recruiting
NCT00579566 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 897-participant average among 122 other Sarcoma trials with a reported enrollment target (234% higher).
The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which Specimen protocol is the first listed.
NCT00579566 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT00579566 about?
NCT00579566 is a clinical study titled "Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma". The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatm...
What is the current status of trial NCT00579566?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2002-06. Estimated completion is 2026-06.
What conditions does trial NCT00579566 study?
This clinical trial studies the following conditions: Sarcoma.
What interventions are being tested in trial NCT00579566?
The interventions under investigation include: Specimen protocol (OTHER).
Who is sponsoring clinical trial NCT00579566?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00579566 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00579566's enrollment target sits among peer trials
3,000 7th of 122 higher than 116 of 122 other Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
RECRUITING
-
Palbociclib and Pembrolizumab in Sarcoma
RECRUITING · Phase 1
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RECRUITING · Phase 1
-
Enhanced Recovery After Surgery in Extremity Sarcoma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
- NCT01205815 · 3,000 participants
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia